Grants

Funding Agency:
Melanoma Research Foundation

Since 1998, the MRF has funded 269 innovative, high impact, basic, translational and clinical research projects. Further, in 2022, the MRF awarded over $1,913,000 in new melanoma research funding. In 2023, the MRF will offer Established Investigator Awards, Career Development Awards (as discussed in the primary Request for Proposals (RFP) ), a CURE OM Award, as well as Medical Student Awards, Resident-Fellow Awards, Mid-Career Bridge Grants and a MRF Breakthrough Consortium (MRFBC) Pilot Translational Award. 

Mid-Career Bridge Grants

In response to a growing need in the field, the MRF has established its Mid-Career Bridge Grant to support investigators who are dedicated to melanoma research. This award will be for established researchers with pre-existing R01s, who have applied for a NIH R01 grant that was scored, but not funded. To support and sustain these investigators while they generate the data for the Response to Reviewers in the revised R01 (A1) submission, the MRF is offering bridge funding of up to $100,000 for one year. These awards will be competed 3 times in 2023 and application submission deadlines are on April 14th, August 15th, or December 15th, 2023.

Medical Student Research Grants

Purpose: To promote research opportunities to medical students early in their careers by funding clinical or laboratory-based research projects focused on better understanding the prevention, early detection, behaviors that impact melanoma risk, biology and treatment of melanoma, including cutaneous, ocular, mucosal, pediatric, etc. In 2024, in addition to awards focused on any aspect of melanoma research, the MRF is please to also offer at least one award focused specifically on ocular melanoma research. Applications will be accepted until November 15, 2023.

 

Resident/Fellow Research Grants

Due to the success of the Medical Student Research Grant program, in 2024 the MRF will introduce resident/fellow research grants as well. The purpose of these 1-year, $10,000 awards is to promote research opportunities to resident/fellows early in their careers by funding clinical or laboratory-based research projects focused on better understanding the prevention, early detection, behaviors that impact melanoma risk, biology and treatment of melanoma, including cutaneous, ocular, mucosal, pediatric, etc. In 2024, in addition to awards focused on any aspect of melanoma research, the MRF is pleased to also offer at least one award focused specifically on ocular melanoma research. Applications for 2024 grants will be accepted until January 31, 2024.

 

MRF Breakthrough Consortium (MRFBC) Pilot Translational Award Funded by the Brodman Charitable Fund & Friends

This one-year pilot proposal for $50,000 focuses on clinical/ translational research. As this is a pilot award, preliminary data is not required. The goal of the pilot proposal is to create findings that could then lend themselves to larger, multicenter grant proposals. Both tenured and non-tenured track faculty are encouraged to apply. Applications for 2024 grants will be accepted until February 20th, 2024.

 

MRF Breakthrough Consortium Young Investigator Team Award to Advance the Field of Translational Immuno-Oncology (MRFBC)

The MRFBC Team Award provides funding of up to $150,000 per year for two years to an investigative team whose research focuses on either improving clinical outcomes for patients with melanoma being treated with immuno‐oncology agents or advancing the scientific understanding of immuno‐oncology and the role of the immune system in melanoma. Teams must involve collaborations from at least two different institutions, one of which must be a MRFBC member institution. Further, the proposed PI and all co-PIs must be junior scientists, all of whom have at least one mentor. Applications for 2024 grants will be accepted until March 1st, 2024.

 

Established Investigator Awards (EIA)

The EIAs provide funding of up to $125,000 per year for two years to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. Applications for 2024 grants will be accepted until March 1st, 2024.

 

Career Development Awards (CDA)

The CDAs provide funding of up to $50,000 per year for two years to junior investigators. Researchers who are beginning a research career focused on melanoma are eligible. This year, in addition to general CDAs, the MRF will offer the MRF Prevention Award in Honor of Teddi Mellencamp/ PREV CDA. Applications for 2024 grants will be accepted until March 1st, 2024.

 

Eligibility

Faculty
Grad/Prof Students
Medical Fellow/Resident

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

March 1, 2024